Transplantation · 1997 · 87 citations · 7 references
Life SciencesImmunologyPathobiologyImmunopathologyInflammationTransplant ImmunologyAcute RejectionComplement SystemComplement-mediated InjuryImmunosuppressionTransplant RejectionBolus RegimensCardiac Myocyte InjuryComplement In Transplant RejectionComplement In TransplantationContinuous Subcutaneous Infusion
A single bolus of soluble complement (C) receptor type 1 (sCR1, TP-10) has been shown to delay hyperacute rejection (HAR) of porcine cardiac xenografts (Xgs) by primate recipients. In these recipients, C activity slowly returned and C deposition was noted in the Xgs at rejection. To evaluate the effect of sustained C inhibition using sCR1 on HAR, two additional cynomolgus monkeys received porcine cardiac Xgs and a continuous infusion of sCR1. In the first recipient, Xgs survival was 5 days (120+ hr), whereas in the second, Xg survival was 7 days (168+ hr). Serial biopsies of the Xgs were remarkable for an increasing cellular infiltrate composed predominantly of neutrophils and macrophages, and the development of edema, hemorrhage, and myocyte necrosis. These findings suggest that once C-mediated HAR has been inhibited, infiltration of the Xg by these cells may lead to accelerated acute rejection, which is an additional barrier to successful longer term Xg survival.
7
PROLONGATION OF CARDIAC XENOGRAFT SURVIVAL BY DEPLETION OF COMPLEMENT
Joseph R. Leventhal, Agustin P. Dalmasso, John W. Cromwell et al. · Transplantation · 1993 · 321 citations
THE EFFECT OF SOLUBLE COMPLEMENT RECEPTOR TYPE 1 ON HYPERACUTE XENOGRAFT REJECTION
Scott K. Pruitt, William M. Baldwin, Henry C. Marsh et al. · Transplantation · 1991 · 151 citations
Medicine, Immunology, Pharmacology +12
Microvascular effects of anaphylatoxins C3a and C5a.
J Björk, Tony E. Hugli, G. Smedegård · The Journal of Immunology · 1985 · 137 citations